Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence DOI Creative Commons
Efthalia Angelopoulou, Efstratios‐Stylianos Pyrgelis, Christina Piperi

и другие.

Molecules, Год журнала: 2022, Номер 27(23), С. 8448 - 8448

Опубликована: Дек. 2, 2022

Neurodegenerative diseases constitute a broad range of central nervous system disorders, characterized by neuronal degeneration. Alzheimer’s disease, Parkinson’s amyolotrophic lateral sclerosis (ALS), and progressive forms multiple (MS) are some the most frequent neurodegenerative diseases. Despite their diversity, these share common pathophysiological mechanisms: abnormal aggregation disease-related misfolded proteins, autophagosome–lysosome pathway dysregulation, impaired ubiquitin–proteasome system, oxidative damage, mitochondrial dysfunction excessive neuroinflammation. There is still no effective drug that could halt progression diseases, current treatments mainly symptomatic. In this regard, development novel multi-target pharmaceutical approaches presents an attractive therapeutic strategy. Ibudilast, anti-inflammatory firstly developed as asthma treatment, cyclic nucleotide phosphodiesterases (PDEs) inhibitor, which acts increasing amount adenosine monophosphate (cAMP) guanosine (cGMP), while downregulating pro-inflammatory factors, such tumor necrosis factor-α (TNF-α), macrophage migration inhibitory factor (MIF) Toll-like receptor 4 (TLR-4). The preclinical evidence shows ibudilast may act neuroprotectively in suppressing neuroinflammation, inhibiting apoptosis, regulating function affecting pathways, well attenuating stress. clinical trials ALS MS also show promising results. Herein, we aim to provide update on emerging potential discuss challenges suggest future directions.

Язык: Английский

Glaucoma: now and beyond DOI
Hari Jayaram, Miriam Kolko, David S. Friedman

и другие.

The Lancet, Год журнала: 2023, Номер 402(10414), С. 1788 - 1801

Опубликована: Сен. 21, 2023

Язык: Английский

Процитировано

144

Inflammation and DNA damage: cause, effect or both DOI
Antonio Pezone, Fabiola Olivieri,

Maria Vittoria Napoli

и другие.

Nature Reviews Rheumatology, Год журнала: 2023, Номер 19(4), С. 200 - 211

Опубликована: Фев. 7, 2023

Язык: Английский

Процитировано

97

Infiltrating CD8+ T cells exacerbate Alzheimer’s disease pathology in a 3D human neuroimmune axis model DOI
Mehdi Jorfi, Joseph Park,

Clare K. Hall

и другие.

Nature Neuroscience, Год журнала: 2023, Номер 26(9), С. 1489 - 1504

Опубликована: Авг. 24, 2023

Язык: Английский

Процитировано

91

Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments DOI
Muneeb U. Rehman, Nouroz Sehar, Nawab John Dar

и другие.

Neuroscience & Biobehavioral Reviews, Год журнала: 2022, Номер 144, С. 104961 - 104961

Опубликована: Ноя. 14, 2022

Язык: Английский

Процитировано

75

Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance DOI Creative Commons
Dnyandev Gadhave, Vrashabh V. Sugandhi, Saurav Kumar Jha

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 99, С. 102357 - 102357

Опубликована: Июнь 1, 2024

Neurodegenerative disorders (NDs) are expected to pose a significant challenge for both medicine and public health in the upcoming years due global demographic changes. NDs mainly represented by degeneration/loss of neurons, which is primarily accountable severe mental illness. This neuronal degeneration leads many neuropsychiatric problems permanent disability an individual. Moreover, tight junction brain, blood-brain barrier (BBB)has protective feature, functioning as biological that can prevent medicines, toxins, foreign substances from entering brain. However, delivering any medicinal agent brain (i.e., Multiple sclerosis, Alzheimer's, Parkinson's, etc.) enormously challenging. There approved therapies address NDs, but most them only help treat associated manifestations. The available have failed control progression certain factors, i.e., BBB drug-associated undesirable effects. extremely complex pathology, with pathogenic mechanisms involved initiation progression; thereby, limited survival rate has been observed ND patients. Hence, understanding exact mechanism behind crucial developing alternative approaches improving patients' rates. Thus, present review sheds light on different cellular novel therapeutic their clinical relevance, will assist researchers alternate strategies limitations conventional therapies. current work offers scope into near future improve approach NDs.

Язык: Английский

Процитировано

28

Collagen in the central nervous system: contributions to neurodegeneration and promise as a therapeutic target DOI Creative Commons
Lauren K. Wareham, Robert O. Baratta, Brian J. Del Buono

и другие.

Molecular Neurodegeneration, Год журнала: 2024, Номер 19(1)

Опубликована: Янв. 25, 2024

Abstract The extracellular matrix is a richly bioactive composition of substrates that provides biophysical stability, facilitates intercellular signaling, and both reflects governs the physiological status local microenvironment. in central nervous system (CNS) far from simply an inert scaffold for mechanical support, instead conducting active role homeostasis providing broad capacity adaptation remodeling response to stress otherwise would challenge equilibrium between neuronal, glial, vascular elements. A major constituent collagen, whose characteristic triple helical structure renders biochemical stability enable bidirectional crosstalk resident cells. Multiple members collagen superfamily are critical neuronal maturation circuit formation, axon guidance, synaptogenesis brain. In mature tissue, interacts with other fibrous proteins glycoproteins sustain three-dimensional medium through which complex networks cells can communicate. While scaffolding, CNS also highly dynamic, multiple binding sites partnering proteins, cell-surface receptors, ligands. These interactions emerging as mediators disease injury, particularly regarding changes stiffness, astrocyte recruitment reactivity, pro-inflammatory signaling microenvironments. Changes and/or deposition impact cellular tissue biomechanics brain, turn alter responses including antigenicity, angiogenesis, gliosis, immune-related factors, each involving contribute limited regeneration tissue. Emerging therapeutics attempt rebuild using peptide fragments, collagen-enriched scaffolds mimetics, hold great potential promote neural repair regeneration. Recent evidence our group others indicates repairing protease-degraded helices mimetic peptides helps restore survival spectrum degenerative conditions. Restoration likely involves bolstering stiffness reduce reactivity inflammation well inhibitory immune-signaling Facilitating rather than endogenous replacement degraded by or injury may represent next frontier developing therapies based on protection, repair, neurons system.

Язык: Английский

Процитировано

22

Vulnerability of the Hippocampus to Insults: Links to Blood–Brain Barrier Dysfunction DOI Open Access
Terry L. Davidson, Richard J. Stevenson

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(4), С. 1991 - 1991

Опубликована: Фев. 6, 2024

The hippocampus is a critical brain substrate for learning and memory; events that harm the can seriously impair mental behavioral functioning. Hippocampal pathophysiologies have been identified as potential causes effects of remarkably diverse array medical diseases, psychological disorders, environmental sources damage. It may be more vulnerable than other areas to insults are related these conditions. One purpose this review assess vulnerability most prevalent types in multiple biomedical domains (i.e., neuroactive pathogens, neurotoxins, neurological conditions, trauma, aging, neurodegenerative disease, acquired injury, health endocrine developmental disabilities, nutrition) evaluate whether affect first prominently compared loci. A second consider role hippocampal blood–brain barrier (BBB) breakdown either causing or worsening harmful each insult. Recent research suggests BBB fragile also prone disruption transport mechanisms act maintain internal milieu. Moreover, compromised could factor common many different insults. Our analysis indicates parts brain, developing interventions protect help prevent ameliorate on memory cognition.

Язык: Английский

Процитировано

15

Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets DOI Creative Commons
Zdeněk Fišar

Biomolecules, Год журнала: 2022, Номер 12(11), С. 1676 - 1676

Опубликована: Ноя. 11, 2022

Damage or loss of brain cells and impaired neurochemistry, neurogenesis, synaptic nonsynaptic plasticity the lead to dementia in neurodegenerative diseases, such as Alzheimer's disease (AD). Injury synapses neurons accumulation extracellular amyloid plaques intracellular neurofibrillary tangles are considered main morphological neuropathological features AD. Age, genetic epigenetic factors, environmental stressors, lifestyle contribute risk AD onset progression. These factors associated with structural functional changes brain, leading cognitive decline. Biomarkers reflect cause specific function, especially pathways neurotransmission, neuroinflammation, bioenergetics, apoptosis, oxidative nitrosative stress. Even initial stages, is Aβ neurotoxicity, mitochondrial dysfunction, tau neurotoxicity. The integrative amyloid-tau-mitochondrial hypothesis assumes that primary neurotoxicity oligomers oligomers, their mutual synergy. For development new efficient drugs, targeting elimination potentiation effects, unwanted protein interactions biomarkers (mainly dysfunction) early stage seems promising.

Язык: Английский

Процитировано

53

Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation DOI Creative Commons
Flora Tassone, Dragana Protić, Emily G. Allen

и другие.

Cells, Год журнала: 2023, Номер 12(18), С. 2330 - 2330

Опубликована: Сен. 21, 2023

The premutation of the fragile X messenger ribonucleoprotein 1 (

Язык: Английский

Процитировано

33

Periodontal Pathogens and Their Links to Neuroinflammation and Neurodegeneration DOI Creative Commons
David Visentin, Ivana Gobin, Željka Maglica

и другие.

Microorganisms, Год журнала: 2023, Номер 11(7), С. 1832 - 1832

Опубликована: Июль 18, 2023

Pathogens that play a role in the development and progression of periodontitis have gained significant attention due to their implications onset various systemic diseases. Periodontitis is characterized as an inflammatory disease gingival tissue mainly caused by bacterial pathogens. Among them, Porphyromonas gingivalis, Treponema denticola, Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans, Tannerella forsythia are regarded main periodontal These pathogens elicit release cytokines, which combination with virulence factors induce chronic inflammation subsequently impact neural function while also altering permeability blood–brain barrier. The primary objective this review summarize existing information regarding pathogens, factors, potential association neuroinflammation neurodegenerative We systematically reviewed longitudinal studies investigated between disorders. Out 24 examined, 20 showed some degree positive correlation disorders, focusing on cognitive demonstrating most robust effects. Therefore, might represent exciting new approach develop novel preventive treatments for

Язык: Английский

Процитировано

31